Luxury brand agency to promote clinical trials for cancer treatment

Issa PR, a boutique agency known for its work for the likes of Absolut Vodka and Def Jam Records, has been appointed by Hamlet Pharma to promote the first major clinical trials for a new cancer treatment.

Researchers at Hamlet Pharma's lab at the University of Lund in Sweden, examining images of lung cancer cells
Researchers at Hamlet Pharma's lab at the University of Lund in Sweden, examining images of lung cancer cells

Human Alpha-lactalbumin Made Lethal to Tumour cells (HAMLET) are a biological substance formed by two molecules naturally present in breast milk – the alpha-lactalbumin protein and oleic acid.

To date it has been found to kill more than 40 types of cancer cells in vitro, including brain and colon cancers.

The Swedish pharma firm approached Issa PR directly, after noticing work the agency had done for the United Nations and Vogue Italia.


It has been appointed to boost Hamlet Pharma’s profile in the UK and US, and will handle comms around clinical trials involving 40 patients with bladder cancer that are currently taking place in the Czech Republic.

Plans are underway to launch the results in the coming weeks. Further work will be done on subsequent clinical trials of the drug.

The agency also aims to secure sufficient interest for a documentary to be produced about the work of Hamlet Pharma in developing what could be a game-changing cancer treatment.

Breaking new ground

It is the first time that Hamlet Pharma has conducted a PR campaign and the business is Issa PR’s first health-sector client.

Professor Catharina Svanborg, chair and founder of Hamlet Pharma

Professor Catharina Svanborg (pictured above), chair and founder of Hamlet Pharma, said: "'We are thrilled to select Issa PR to help launch our first major clinical trials for HAMLET in hope of finding a cure for multiple types of cancer."

She added: "We selected Issa PR given their impressive work for clients around the globe, as well as extensive depth and breadth in both philanthropy and launching groundbreaking world news."

Viet N’Guyen, chief executive and founder of Issa PR

Viet N’Guyen (pictured above), chief executive and founder of Issa PR, commented: "We are deeply honoured to represent HAMLET in their efforts to find a possible cure for cancer."

Click here to subscribe to the FREE pharma and healthcare comms bulletin to receive dedicated healthcare news, features and comment straight to your inbox.

Make sure you register for the site to access more than one story per month.

To submit a news, comment, case study or analysis idea for the pharma and healthcare comms bulletin, email

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in